ABCC7 p.Asp572Ala

ClinVar: c.1714G>A , p.Asp572Asn ? , not provided
CF databases: c.1714G>A , p.Asp572Asn (CFTR1) ? , The nucleotide change G->A at nucleotide position 1846 leads to D572N in exon 12. This variation was observed on one CF chromosome in collaboration with Dr Kapranov (Moscow, Russia)
c.1714G>C , p.Asp572His (CFTR1) ? ,
Predicted by SNAP2: A: D (95%), C: D (95%), E: D (95%), F: D (95%), G: D (95%), H: D (95%), I: D (95%), K: D (95%), L: D (95%), M: D (95%), N: D (53%), P: D (95%), Q: D (95%), R: D (95%), S: D (95%), T: D (95%), V: D (95%), W: D (95%), Y: D (95%),
Predicted by PROVEAN: A: D, C: D, E: D, F: D, G: D, H: D, I: D, K: D, L: D, M: D, N: D, P: D, Q: D, R: D, S: D, T: D, V: D, W: D, Y: D,

[switch to compact view]
Comments [show]
Publications
[hide] Powell K, Zeitlin PL
Therapeutic approaches to repair defects in deltaF508 CFTR folding and cellular targeting.
Adv Drug Deliv Rev. 2002 Dec 5;54(11):1395-408., [PMID:12458151]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Sato S, Ward CL, Krouse ME, Wine JJ, Kopito RR
Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation.
J Biol Chem. 1996 Jan 12;271(2):635-8., [PMID:8557666]

Abstract [show]
Comments [show]
Sentences [show]